These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32679015)

  • 1. An Insight into Unani Hypoglycemic Drugs and Their Mechanism of Action.
    Fazil M; Nikhat S; Ali I
    Comb Chem High Throughput Screen; 2021; 24(2):165-176. PubMed ID: 32679015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Evaluation of Unani Medicine, Including Single Drugs and Polyherbal Formulations with Special Reference to Neurodegenerative Disorders.
    Imran S; Ahmad W; Saltanat S
    Altern Ther Health Med; 2024 Sep; 30(9):54-64. PubMed ID: 39212516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs
    Akhlaq S; Ara SA; Itrat M; Fazil M; Ahmad B; Akram U; Haque M; Quddusi N; Sayeed A
    Curr Drug Targets; 2024; 25(1):1-11. PubMed ID: 38115618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unani Medicines for Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review.
    Itrat M; Nasir F; K R; Khan TN; Tayyeb Bukhari STT
    Altern Ther Health Med; 2024 Jun; 30(6):46-51. PubMed ID: 38843419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based Unani Pharmacotherapeutics for the Treatment of Non-Alcoholic Fatty Liver Disease: A Mechanistic Review.
    Nasir F; Itrat M; Khan F
    Altern Ther Health Med; 2024 Aug; 30(8):32-42. PubMed ID: 39110048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Treatment of Upper Respiratory Tract Infections in Unani Medicine: An Evidence-Based Review.
    Itrat M; Nasir F; Akhtar Y; Ahmad I
    Altern Ther Health Med; 2023 Oct; 29(7):252-261. PubMed ID: 36302235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical medicines for wound healing: A systematic review of Unani literature with recent advances.
    Fazil M; Nikhat S
    J Ethnopharmacol; 2020 Jul; 257():112878. PubMed ID: 32325180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Requirements for Quality Control of Unani Medicines.
    Rai N; Joshi SK; Sharma RK
    J AOAC Int; 2020 Jun; 103(3):634-648. PubMed ID: 31561755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unani medicinal herbs as potential air disinfectants: an evidence-based review.
    Mahfooz S; Itrat M; Uddin H; Khan TN
    Rev Environ Health; 2022 Jun; 37(2):155-168. PubMed ID: 34384009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific appraisal of Unani concept of islah-e-advia (rectification/purification of drugs) and its importance.
    Rahman S; Jahan N; Makbul SAA; Ahmad M; Gani MA
    J Ethnopharmacol; 2020 Aug; 258():112880. PubMed ID: 32360562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector-control potential of Unani medicines: A review of classical Unani texts and contemporary scientific literature.
    Shahabuddin F; Itrat M; Kumar S
    J Vector Borne Dis; 2024 Jul; 61(3):315-326. PubMed ID: 38287745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress with thiazolidinediones in the management of type 2 diabetes mellitus.
    Meriden T
    Clin Ther; 2004 Feb; 26(2):177-90. PubMed ID: 15038941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.
    Johansen OE; Birkeland KI
    Am J Cardiovasc Drugs; 2007; 7(5):319-35. PubMed ID: 17953471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic agents in the management of type 2 diabetes mellitus.
    Ho J; Leung AK; Rabi D
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):66-73. PubMed ID: 22074580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concepts and Quality Considerations in Unani System of Medicine.
    Parveen A; Parveen R; Akhatar A; Parveen B; Siddiqui KM; Iqbal M
    J AOAC Int; 2020 Jun; 103(3):609-633. PubMed ID: 31547901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yang L; Chen J; Lu H; Lai J; He Y; Liu S; Guo X
    Am J Chin Med; 2019; 47(7):1419-1444. PubMed ID: 31659910
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin action enhancers for the management of type 2 diabetes mellitus.
    Valsamakis G; Kumar S
    Expert Opin Pharmacother; 2000 Dec; 1(7):1413-21. PubMed ID: 11249474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.